Things to Do
Emory to conduct H1N1 vaccine trial in asthma sufferers
Emory University will participate in a clinical trial to study what dose of the 2009 H1N1 vaccine is needed to build up an effective immunity in people with asthma, particularly those with severe cases of the respiratory disease.
The study is co-sponsored by the National Institute of Allergy and Infectious Diseases and the National Heart, Lung and Blood Institute, both are part of the National Institutes of Health.
People with underlying conditions, such as asthma, are at greater risk of developing complications from the disease. The trials will be conducted at Emory and six other sites that participate in the NHLBI's Severe Asthma Research Program. At Emory, the program is through the Emory-Children's Center, which is jointly run by Emory and Children's Healthcare of Atlanta.
About 350 people with mild, moderate and severe asthma will be enrolled in the overall study. At Emory, no volunteers are needed. The participants will be selected from people already involved in the exisiting asthma research program.
